Skip to main content
Wanbury Limited logo

Wanbury Limited — Investor Relations & Filings

Ticker · WANBURY ISIN · INE107F01022 LEI · 335800QB384KGMBID276 BSE.NS Manufacturing
Filings indexed 912 across all filing types
Latest filing 2025-09-18 Regulatory Filings
Country IN India
Listing BSE.NS WANBURY

About Wanbury Limited

https://www.wanbury.com

Wanbury Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and finished formulations. The organization maintains a significant global presence, particularly as a leading producer of Metformin. Its product portfolio spans diverse therapeutic areas, including gynecology, orthopedics, hematinics, and anti-diabetics. The company operates manufacturing facilities compliant with international regulatory standards, including the USFDA. Wanbury focuses on providing medicinal solutions through integrated research and development capabilities and large-scale production infrastructure, serving both domestic and international markets with a range of specialty products.

Recent filings

Filing Released Lang Actions
Appointment
Regulatory Filings
2025-09-18 English
Allotment of 20,00,000 (Twenty Lakhs) equity shares pursuant to conversion of convertible warrants.
Regulatory Filings
2025-09-18 English
Committee Meeting Updates
Regulatory Filings
2025-09-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document text is extremely short (637 characters) and contains only a digital signature block with no substantive content or financial data. There is no indication of a report, announcement, or any specific filing type. Given the lack of content and the presence of a digital signature, this document is best classified as a Regulatory Filing (RNS), which serves as a fallback category for miscellaneous filings that do not fit other categories.
2025-09-18 English
Schedule of analyst/investor meetings
Regulatory Filings
2025-09-18 English
Register of Member and Share Transfer Book of the Company will remain closed from Friday, 12th September, 2025 to Thursday, 18th September, 2025 (both days inclusive) for the purpose of ....
Regulatory Filings
2025-08-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.